AIT Therapeutics Reports Financial Results for First Fiscal Quarter 2019

Aug 14, 2018 8:00am EDT

AIT Therapeutics Announces $20 Million Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund

Aug 13, 2018 8:30am EDT

AIT Therapeutics Schedules Fiscal First Quarter 2019 Financial Results Conference Call and Webcast

Aug 01, 2018 4:15pm EDT

AIT Therapeutics Announces Start of Manufacturing of Ventilator Compatible NO Generator and Delivery System

Jul 30, 2018 8:30am EDT

AIT Therapeutics Announces Human and In-Vitro Nitric Oxide (NO) Data Presented at the 3rd Annual World Bronchiectasis Conference

Jul 16, 2018 8:30am EDT

AIT Therapeutics Announces Human and In-Vitro Nitric Oxide Data to be Presented at the 3rd Annual World Bronchiectasis Conference

Jun 27, 2018 4:30pm EDT

AIT Therapeutics Reports Financial Results for Three Months Ended March 31, 2018

Jun 14, 2018 8:00am EDT

AIT Therapeutics Reports Positive Top Line Results from its Nitric Oxide in Bronchiolitis (NO-BRO) Pilot Study in Infants

Jun 13, 2018 4:30pm EDT

AIT Therapeutics Announces Change to Fiscal Year End and Financial Results Conference Call and Webcast for the Three Months Ended March 31, 2018

Jun 07, 2018 4:17pm EDT

AIT Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

May 30, 2018 4:30pm EDT